Atypical calcineurin inhibitor-induced haemolytic uremic syndrome after liver transplantation

Annals of Transplantation

Volumn 14, Issue 4, 2009, Pages 47-51

  Furmańczyk, Agnieszka ^a   Komuda Leszek, Ewa ^a   Durlik, Magdalena ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Atypical HUS; Liver transplantation; Thrombotic microangiopathy

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ARTICLE; BILE DUCT DILATATION; CASE REPORT; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT SURVIVAL; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; RETRANSPLANTATION; THROMBOCYTOPENIA;

ADULT; FATAL OUTCOME; GRAFT REJECTION; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; TACROLIMUS;

EID: 74949129206     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Myśliwiec M: Thrombotic microangiopathies - advances in pathogenesis, diagnostic and therapy Nefrol Dial Pol, 2008: 12(2): 124-27
2. Kozińska-Przyzbył O, Durlik M: Thrombotic microangiopathy (TMA), atypical hemolytic uremic syndrome (aHUS). Pol Arch Med Wewn, 2006; Zeszyt Specjalny: 26-34
3. Sadler Evan J: Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood, 2008; 112(1): 11-18
4. Mannucci Mannuccio P, Canciani MT, Forza I et al: Changes in health and disease of the metaloprotease that cleaves von Willebrand factor. Blood, 2001; 98(9): 2730-35
5. Uemura M, Fujimura Y, Matsumoto M et al: Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis. Thromb Haemost. 2008; 90(6): 1010-29
6. Meglic A, Grosek S, Benedic-Dolnicar M et al: Atypical haemolytic uremic syndrome complicated by microangiopathic antiphospholipid-associated syndrome. Lupus, 2008; 17(9): 842-45
7. Asherson A, Cervera R: Microvascular and microangiopathic antiphospholipid-associated syndrome (MAPS). Semantic or antisemantic? Autoimmunnity Reviews, 2008; 7(3): 164-67